All In MedTech

Device Trial Radar · NCT02663739

Zenith® TXD Post-market Surveillance in Japan

Zenith TXD Dissection Stent Graft System Usage Results Surveillance in Japan for Treating Acute Complicated Stanford Type B Aortic Dissection

Last checked: Nov 20, 2026Latest source record: Jun 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

57

Actual

Start

Mar 2015

Primary completion

Mar 28, 2023

Study completion Mar 28, 2023

Sponsor

Lead sponsor
Cook Group IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Jan 26, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a post-market surveillance study required by Japanese Regulatory Authorities as a condition of approval

Conditions

  • Aortic Dissection

Interventions

  • Zenith® TXDDevice

    Zenith® TXD Dissection Stent Graft System for treatment of patients with aortic dissection of the descending thoracic aorta

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of major adverse eventsTime frame: 5 years

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • Kokura Memorial Hospital

    Fukuoka, Japan

  • Kyushu University Hospital

    Fukuoka, Japan

  • Minami Tohoku Hospital

    Fukushima, Japan

24 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.